Cargando…

Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy

Detalles Bibliográficos
Autores principales: Rizzo, Alessandro, Ricci, Angela Dalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570098/
https://www.ncbi.nlm.nih.gov/pubmed/36232663
http://dx.doi.org/10.3390/ijms231911363
_version_ 1784810022000132096
author Rizzo, Alessandro
Ricci, Angela Dalia
author_facet Rizzo, Alessandro
Ricci, Angela Dalia
author_sort Rizzo, Alessandro
collection PubMed
description
format Online
Article
Text
id pubmed-9570098
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95700982022-10-17 Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy Rizzo, Alessandro Ricci, Angela Dalia Int J Mol Sci Editorial MDPI 2022-09-26 /pmc/articles/PMC9570098/ /pubmed/36232663 http://dx.doi.org/10.3390/ijms231911363 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Rizzo, Alessandro
Ricci, Angela Dalia
Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy
title Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy
title_full Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy
title_fullStr Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy
title_full_unstemmed Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy
title_short Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy
title_sort challenges and future trends of hepatocellular carcinoma immunotherapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570098/
https://www.ncbi.nlm.nih.gov/pubmed/36232663
http://dx.doi.org/10.3390/ijms231911363
work_keys_str_mv AT rizzoalessandro challengesandfuturetrendsofhepatocellularcarcinomaimmunotherapy
AT ricciangeladalia challengesandfuturetrendsofhepatocellularcarcinomaimmunotherapy